Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Dr Harold Gunson wrote to the DCMO Dr Edmund Harris and noted that it was very important that Dr Wallington's proposed study be put into operation as he feared they would otherwise be forced into the cost of anti-HBc testing because of developments in the US.

Published on: 29 July, 2024

Dr Harold Gunson wrote to members of the Central Research Committee AIDS Working Party to circulate an American Association of Blood Banks' newsletter discussing anti-HBc testing, and noted that UK efforts in this direction would be 'timely'.

Published on: 29 July, 2024

At a meeting of the CBLA, Dr Gunson suggested that the application to the MRC made by Dr Wallington for funding was now being modified due to proposed screening tests for HTLV-3/HIV.

Published on: 29 July, 2024

The MRC Working Party on AIDS met where it was recorded that the number of cases of AIDS in the UK was continuing to rise sharply.

Published on: 29 July, 2024

Within Drs Barbara and Tedder's Viral Infections Transmitted by Blood and Its Products Clinic report it was described how it was not known whether this would be a suitable or effective screen for donors who constituted a high risk of transmission of AIDS.

Published on: 29 July, 2024

The "Expert Report to the Infected Blood Inquiry: Statistics" by the Statistics Expert Group identified how donor leaflets had been introduced generally in September 1983.

Published on: 29 July, 2024

Within Professor John Barbara's evidence to the Inquiry he describes how there was some possible merit, certainly worth considering, of anti-HBc as an indication of past or present infection.

Published on: 29 July, 2024

The World Health Organization produced a draft report which accepted that a test, indirectly related to particular risk groups, could theoretically help to identify individuals who were at risk of AIDS.

Published on: 29 July, 2024

NBTS Advisory Committee meeting minutes reported on "a survey of two studies, at Bristol and North London". The proportion of donations which might be excluded by a positive test in Bristol was 0.75%, whereas in North London it was 2.6%. Dr Brian McClelland agreed to submit a proposal for a further study on anti-HBc screening in time for the next meeting early in 1984.

Published on: 29 July, 2024

Anna Soubry told the Inquiry that the various schemes were very difficult for people to access and very little was being done to change the system with respect to Hepatitis C payments.

Published on: 30 July, 2024

A memo was prepared to Anna Soubry with options for reforming the Hepatitis C payments system.

Published on: 30 July, 2024

A memo from Ben Cole to PS(PH) and the Secretary of State concerned the options for reforming the Hepatitis C payments system.

Published on: 30 July, 2024

A memo from Ben Cole to PS(PH) and the Secretary of State sought advice on options for reform on the Hepatitis C payments system.

Published on: 30 July, 2024

The fact that there was very little political will to change the system with respect to Hepatitis C payments was put forward to David Cameron.

Published on: 30 July, 2024

David Cameron held that he was increasingly frustrated at the delay in the publication of the Penrose report, not only for the sake of the victims but also because he was out of time in the Parliament to respond with any meaningful reform.

Published on: 30 July, 2024

David Cameron pledged up to £25 million that financial year to support transitional arrangements to a better payments system as well as apologising for the infected blood scandal on behalf of the Government.

Published on: 10 October, 2024

The Department of Health published its response to the consultation, setting out its decision to have a single scheme administrator which was only applicable to England. The decision was announced by David Cameron on the same day.

Published on: 30 July, 2024

A memo considered how to address the lower end of the spectrum in terms of payments and managing the expectations of campaigners.

Published on: 30 July, 2024

In May 2014 ministers had agreed that there needed to be wholesale reform of the AHOs by rationalising them into one organisation.

Published on: 30 July, 2024

A submission to the Parliamentary Under-Secretary of State for Health, Jane Ellison, advised that there should be consultation with counterparts in Wales, Scotland and Northern Ireland to seek their views about scheme changes.

Published on: 30 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2223
  • Page 2224
  • Page 2225
  • Page 2226
  • Current page 2227
  • Page 2228
  • Page 2229
  • Page 2230
  • Page 2231
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.